Unreliable Survey Doesn’t Sink Mucinex Fast-Max’All In One’Claim In NAD Review

摘要

Reckitt Benckiser Group PLC and Procter & Gamble Co.’s third industry self-regulation bout in three years ended in a draw as some RB ad claims for Mucinex Fast-Max Cold,Flu & Sore Throat withstood a review while others were knocked out on a P&G challenge.RB didn’t get help in its corner from a consumer perception survey it submitted to support its argument that the”All In One”statement on labeling is not a claim that the product treats all cold and flu symptoms.However,while the Council of Better Business Bureaus’National Advertising Division dismissed the survey as faulty,it scored the round for RB’s argument anyway.